Experience
Avara

Experience Avara

William L. Pasek

Executive Vice President/Chief Commercial Officer

Recent Posts

Jan 18, 2018 8:00:00 AM

AAPS PHARMSCI 360 – NOV 4-7, 2018

by William L. Pasek

Washington, DC
avara_aaps2018.jpg
VISIT US AT BOOTH #2142
AAPS developed PharmSci 360 after reconsidering every aspect of the meeting experience, including how programming is selected, how the day is structured, and the role of our industry partners in delivering the event. This new meeting takes advantage of the greatest strength of the AAPS community: Our members’ ability to deliver cross-discipline learning experiences. 

Read More [fa icon="long-arrow-right"]
Topics: Events

Sep 21, 2017 11:44:39 AM

Avara Pharmaceutical Services acquires Secondary Manufacturing and Packaging facility from GSK in Aiken, South Carolina

by William L. Pasek


Avara Pharmaceutical Services is a world class contract development and manufacturing organization (CDMO) with an extensive network serving the global bio-pharmaceutical market

Avara Pharmaceutical Services has signed an agreement with GSK to acquire a GSK Secondary Manufacturing and Packaging facility in Aiken, South Carolina. "This acquisition is an important component of our strategic plan and expands our services by adding additional solid dose capability in the United States, which is in very high demand," stated Timothy C. Tyson, Chairman and CEO. The transaction is expected to complete on or before June 1, 2018.

Read More [fa icon="long-arrow-right"]
Topics: News

Aug 22, 2017 2:03:16 PM

Avara Pharmaceutical Services acquires Sterile facility from Pfizer in Italy

by William L. Pasek


Avara Pharmaceutical Services is a world class contract development and manufacturing organization (CDMO) with an extensive network serving the global bio-pharmaceutical market

Norwalk, CT, August 2017 -- Avara Pharmaceutical Services has signed an agreement with Pfizer Inc. to acquire the Liscate, Italy sterile manufacturing facility. “This acquisition is an important component of our strategic plan and expands our services by adding sterile processing capability, which is in very high demand”, stated Timothy C. Tyson, Chairman and CEO.

Read More [fa icon="long-arrow-right"]
Topics: News

Mar 27, 2017 4:32:16 PM

A Growing CDMO

by William L. Pasek


Interview with Bill Pasek, Executive Vice President, Chief Commercial Officer

Read More [fa icon="long-arrow-right"]

Sep 19, 2016 8:43:00 AM

Avara Pharmaceutical Services Celebrates One Year Since Launch With Arecibo (PR) Site and Acquisition of Shannon, Ireland Site

by William L. Pasek

 
Created in 2015, Avara Pharmaceutical Services is a state-of-the-art contract development and manufacturing organization (CDMO) providing both primary formulation and manufacturing, and secondary manufacturing and packaging of small molecules.

Read More [fa icon="long-arrow-right"]
Topics: News

Sep 6, 2016 10:46:00 AM

Avara Acquires AstraZeneca UK Manufacturing Facility

by William L. Pasek


Norwalk, CT, September 6, 2016
- Avara Pharmaceutical Services, Inc. (“Avara”) today announced that they have entered into an agreement under which Avara will acquire AstraZeneca’s manufacturing facility located in Avlon, Avonmouth, England.

Read More [fa icon="long-arrow-right"]
Topics: News

Aug 3, 2016 11:02:00 AM

Avara Acquires Astellas U.S. Manufacturing Facility

by William L. Pasek


Norwalk, CT, August 3rd, 2016 –Avara Pharmaceutical Services, Inc. announced that its subsidiary, Avara Norman Pharmaceutical Services, Inc. (“Avara”) entered into an agreement under which Avara will acquire Astellas’s wholly owned manufacturing subsidiary Astellas Pharma Technologies (APT), Inc., located in Norman, Oklahoma. 

Read More [fa icon="long-arrow-right"]
Topics: News